Levin Capital Strategies, L.P. Abbott Laboratories Transaction History

Levin Capital Strategies, L.P.

  • $1.01 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$96.76 - $112.03 $24,190 - $28,007
-250 Reduced 6.85%
3,400 $329,000
Q2 2022

Aug 15, 2022
SELL
$102.07 - $123.37 $25,517 - $30,842
-250 Reduced 6.41%
3,650 $397,000
Q3 2020

Nov 17, 2020
BUY
$91.64 - $111.29 $357,396 - $434,031
3,900 New
3,900 $424,000

Others Institutions Holding ABT

# of Institutions
3,244
Shares Held
1.31B
Call Options Held
8.71M
Put Options Held
8.03M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Levin Capital Strategies, L.P. Portfolio

Follow Levin Capital Strategies, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email